Immunocytokines for cancer treatment: past, present and future

被引：87
|
作者：
Neri, Dario [1 ]
Sondel, Paul M. [2 ,3 ,4 ,5 ]
机构：
[1] ETH, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland
[2] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Human Oncol, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA
[5] Univ Wisconsin, UW Carbone Canc Ctr, Madison, WI 53706 USA
来源：
CURRENT OPINION IN IMMUNOLOGY | 2016年 / 40卷
基金：
瑞士国家科学基金会; 美国国家卫生研究院;
关键词：
TUMOR-TARGETING PROPERTIES; CYTOKINE FUSION PROTEINS; ANTIBODY-BASED DELIVERY; ANTITUMOR-ACTIVITY; MEDIATED DELIVERY; MELANOMA PATIENTS; DOSE-ESCALATION; SOLID TUMORS; STAGE-III; T-CELLS;
D O I：
10.1016/j.coi.2016.03.006
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Immunocytokines are antibody-cytokine fusion proteins, with the potential to preferentially localize on tumor lesions and to activate anticancer immunity at the site of disease. Various tumor targets (e.g., cell membrane antigens and extracellular matrix components) and antibody formats (e.g., intact IgG and antibody fragments) have been considered for immunocytokine development and some products have advanced to clinical trials. In this review, we present relevant concepts and strategies for the design and use of anticancer immunocytokine products. In addition, we discuss emerging strategies for the pharmaceutical development and clinical application of this promising class of biopharmaceuticals.
引用
收藏
页码：96 / 102
页数：7
相关论文
共 50 条
  • [1] The present and future of immunocytokines for cancer treatment
    Dennis Y. Gout
    Lotte S. Groen
    Marjolein van Egmond
    [J]. Cellular and Molecular Life Sciences, 2022, 79
  • [2] The present and future of immunocytokines for cancer treatment
    Gout, Dennis Y.
    Groen, Lotte S.
    van Egmond, Marjolein
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (10)
  • [3] The evolution of treatment for gastric cancer: Past, present, and future
    Poruk, Katherine E.
    Strong, Vivian E.
    [J]. SURGERY, 2021, 170 (01) : 11 - 12
  • [4] Treatment in esophagogastric junction cancer: Past, present and future
    Pericay, Caries
    Macias-Declara, Ismael
    Arrazubi, Virginia
    Vila, Laia
    Marin, Miguel
    [J]. CIRUGIA ESPANOLA, 2019, 97 (08): : 459 - 464
  • [5] Chemotherapy in the Treatment of Prostate Cancer - The Past, the Present, and the Future
    Sundararajan, Srinath
    Vogelzang, Nicholas
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (06) : 14 - 21
  • [6] Hormonal treatment of endometrial cancer: past, present and future
    Podczaski, E
    Mortel, R
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2001, 15 (03): : 469 - 489
  • [7] Gene Therapy for Cancer Treatment: Past, Present and Future
    Cross, Deanna
    Burmester, James K.
    [J]. CLINICAL MEDICINE & RESEARCH, 2006, 4 (03) : 218 - 227
  • [8] Diethylstilboestrol for the treatment of prostate cancer: past, present and future
    Turo, Rafal
    Smolski, Michal
    Esler, Rachel
    Kujawa, Magda L.
    Bromage, Stephen J.
    Oakley, Neil
    Adeyoju, Adebanji
    Brown, Stephen C. W.
    Brough, Richard
    Sinclair, Andrew
    Collins, Gerald N.
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (01) : 4 - 14
  • [9] Adjuvant treatment of colon cancer: Past, present and future
    Wils, J.
    [J]. JOURNAL OF CHEMOTHERAPY, 2007, 19 (02) : 115 - 122
  • [10] Past, Present, and Future Challenges in Breast Cancer Treatment
    Sledge, George W.
    Mamounas, Eleftherios P.
    Hortobagyi, Gabriel N.
    Burstein, Harold J.
    Goodwin, Pamela J.
    Wolff, Antonio C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 1979 - 1986
12345